Porton Pharma Solutions Ltd. (SHE:300363)
China
· Delayed Price · Currency is CNY 21.28
-0.60 (-2.74%)
Apr 29, 2026, 3:06 PM CST
Porton Pharma Solutions Revenue
Porton Pharma Solutions had revenue of 886.04M CNY in the quarter ending March 31, 2026, with 10.59% growth. This brings the company's revenue in the last twelve months to 3.50B, up 11.78% year-over-year. In the year 2025, Porton Pharma Solutions had annual revenue of 3.42B with 13.54% growth.
Revenue (ttm)
3.50B
Revenue Growth
+11.78%
P/S Ratio
3.29
Revenue / Employee
804.02K
Employees
4,359
Market Cap
11.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.42B | 407.86M | 13.54% |
| Dec 31, 2024 | 3.01B | -655.45M | -17.87% |
| Dec 31, 2023 | 3.67B | -3.37B | -47.87% |
| Jan 1, 2023 | 7.03B | 3.93B | 126.55% |
| Jan 1, 2022 | 3.11B | 1.03B | 49.87% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Mayinglong Pharmaceutical Group | 3.91B |
| Shanghai Yizhong Pharmaceutical | 317.08M |
| Henan Lingrui Pharmaceutical | 3.96B |
| Yantai Dongcheng Pharmaceutical Group | 2.68B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Guangdong Taienkang Pharmaceutical | 674.49M |